The company was alleged to have violated stock brokers’ regulation as well as PFUTP (Prohibition of Fraudulent and Unfair Trade Practices) regulations.
It was alleged that IIFL Wealth Management and
knowingly manipulated the reference price of for a block deal.
Sebi had conducted an examination of block deals to check any manipulation of reference price considered for execution of block deal trades in the scrip of Alkem Laboratories for the period April to September 2019.
Pending the proceedings, IIFL Wealth Management proposed to settle the case without admitting or denying the guilt.
The High Powered Advisory Committee of Sebi considered the settlement terms proposed by the company and recommended the case for settlement on payment of Rs 3.12 crore.
Sebi noted that the amount was remitted by the firm dated July 04, 2022.
“Therefore, in view of the acceptance of the settlement terms and the receipt of the settlement amount as above by Sebi, the instant adjudication proceedings initiated against the noticee…dated April 16, 2021, are disposed of,” it added.
In a regulatory filing on Friday, IIFL Wealth said it has settled the case with Sebi with a view to an early conclusion and to avoid regulatory proceedings.
“We would like to clarify that the matter pertains to the execution of trades by IIFL Wealth as a selling broker for its client in the normal/block window in the shares of Alkem Laboratories Ltd in 2019,” it said.
According to the filing, the company earned only the normal brokerage on the transactions.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.